# Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors

> **NCT03940820** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Asclepius Technology Company Group (Suzhou) Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** ROBO1 CAR-NK cells

## Key facts

- **NCT ID:** NCT03940820
- **Lead sponsor:** Asclepius Technology Company Group (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05
- **Primary completion:** 2021-05
- **Final completion:** 2022-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940820, "Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03940820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*